U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396142) titled 'BaiXiaoAi AI Companion for Cancer Patient Follow-up' on Feb. 01.
Brief Summary: This is a prospective, single-center, exploratory study designed to evaluate the accuracy, user engagement, and user experience of the BaiXiaoAi Companion AI. Upon signing the informed consent form and enrollment, a dedicated "Doctor-Nurse-Patient-AI" WeChat group will be established for each participant. Within the group, the BaiXiaoAi AI will provide timely responses based on patient communications and proactively push information regarding disease management and patient education.
Study Start Date: Jan. 14
Study Type: OBSERVATIONAL
Condition:
Symp...